These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 12460871)
1. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Omland T; Persson A; Ng L; O'Brien R; Karlsson T; Herlitz J; Hartford M; Caidahl K Circulation; 2002 Dec; 106(23):2913-8. PubMed ID: 12460871 [TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related]
3. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344 [TBL] [Abstract][Full Text] [Related]
4. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969 [TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065 [TBL] [Abstract][Full Text] [Related]
6. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study. Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923 [TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Galvani M; Ferrini D; Ottani F Eur J Heart Fail; 2004 Mar; 6(3):327-33. PubMed ID: 14987584 [TBL] [Abstract][Full Text] [Related]
8. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide. Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J; Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326 [TBL] [Abstract][Full Text] [Related]
9. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700 [TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. Morrow DA; de Lemos JA; Sabatine MS; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Gibson CM; Cannon CP; Braunwald E J Am Coll Cardiol; 2003 Apr; 41(8):1264-72. PubMed ID: 12706919 [TBL] [Abstract][Full Text] [Related]
13. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956 [TBL] [Abstract][Full Text] [Related]
14. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
15. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085 [TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes. Yamamoto T; Sato N; Yasutake M; Takagi H; Morita N; Akutsu K; Fujii M; Fujita N; Tanaka K; Takano T Int J Cardiol; 2006 Aug; 111(2):224-30. PubMed ID: 16185779 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953 [TBL] [Abstract][Full Text] [Related]
18. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000 [TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
20. Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome. Bassan F; Bassan R; Esporcatte R; Santos B; Tura B Arq Bras Cardiol; 2016 Mar; 106(3):218-25. PubMed ID: 26840056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]